IGF2BP1 is a newly characterized m6A reader belonging to the insulin‐like growth factor 2 mRNA‐binding protein (IGF2BP) family.[18] IGF2BP1 has been recently reported to enhance tumor stemness by mediating the stabilization of βTrCP1 and c‐MYC mRNAs in response to β‐catenin signaling.[19]. This evidence concerns the gene IGF2BP1 and neoplasm.